TPD52 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of TPD52, a protein associated with various cellular processes. TPD52, short for tumor protein D52, is a cytoplasmic protein that plays a role in intracellular trafficking, endocytosis, and signal transduction pathways. Inhibitors of TPD52 are molecular compounds designed to interfere with the normal function or expression of this protein, often through binding to specific regions or sites within the protein structure. By doing so, they can potentially disrupt cellular processes where TPD52 is involved.
The development of TPD52 inhibitors has garnered interest due to the protein's involvement in several cellular pathways. TPD52 has been implicated in processes such as cell division, membrane trafficking, and vesicle formation. Inhibition of TPD52 may affect these processes, offering insights into the fundamental mechanisms underlying cellular function.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can inhibit TPD52 by interfering with the mTOR signaling pathway, which could influence TPD52-associated processes. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6, which can inhibit TPD52 by affecting the cell cycle, where TPD52 might have a regulatory role. | ||||||